Used primarily as a pharmaceutical intermediate in the synthesis of nicotinic acetylcholine receptor modulators. It plays a key role in developing compounds targeting neurological disorders such as Alzheimer's disease, schizophrenia, and nicotine addiction. Its structure, featuring a pyridine ring and N-methylamine group, allows for selective interaction with receptor subtypes, making it valuable in creating drugs with improved efficacy and reduced side effects. Also utilized in research settings to study cholinergic signaling pathways.